维生素D补充对角质形成细胞癌风险的影响:D-Health随机对照试验的探索性分析
基于D-Health随机安慰剂对照试验,纳入20 334名60岁及以上澳大利亚人,每月补充60 000国际单位维生素D持续5年。结果显示补充维生素D未降低角质形成细胞癌切除发病率(IRR 1.04;95%CI 0.98-1.11)、其他方法治疗的光化性病变发病率(IRR 1.01;95%CI 0.95-1.08)或首次组织学确诊切除时间(HR 1.02;95%CI 0.97-1.08);但亚组分析中70岁及以上成人补充维生素D增加切除发病率(IRR 1.13,95%CI 1.04-1.23;交互作用P=0.01)。
要点
- 每月补充60 000 IU维生素D持续5年未降低角质形成细胞癌切除发病率(IRR 1.04;95%CI 0.98-1.11)。
- 补充维生素D未减少其他方法治疗的光化性病变发病率(IRR 1.01;95%CI 0.95-1.08)。
- 70岁及以上成人亚组中补充维生素D增加角质形成细胞癌切除发病率(IRR 1.13;95%CI 1.04-1.23)。
核心结论
- 补充维生素D未降低角质形成细胞癌或其他光化性病变的发病率。
- 亚组分析中70岁及以上成人补充维生素D增加角质形成细胞癌切除发病率(IRR 1.13,95%CI 1.04-1.23;交互作用P=0.01)。
研究设计与样本
- D-Health试验为随机安慰剂对照试验,纳入60岁及以上澳大利亚人,每月补充60 000国际单位维生素D持续5年。
- 通过链接国家行政数据集获取同意者(N=20 334;95%)的角质形成细胞癌结局。
主要发现
- 随机分配至维生素D补充组未降低切除治疗的角质形成细胞癌病变发病率(IRR 1.04;95%CI 0.98-1.11)。
- 未降低其他方法治疗的光化性病变发病率(IRR 1.01;95%CI 0.95-1.08)。
- 未延长首次组织学确诊角质形成细胞癌切除时间(HR 1.02;95%CI 0.97-1.08)。
- 亚组分析中70岁及以上成人补充维生素D增加角质形成细胞癌切除发病率(IRR 1.13,95%CI 1.04-1.23;交互作用P=0.01)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vitamin D may play a role in prevention of keratinocyte cancer (KC), but observational studies examining the association between serum 25-hydroxy vitamin D concentration and KC are largely uninformative because sun exposure causes both KC and vitamin D production. There is scant evidence from clinical trials of supplementary vitamin D. OBJECTIVES: To examine the effect of vitamin D supplementation on the risk of developing KC. METHODS: We used data from the D-Health Trial, a randomized placebo-controlled trial of vitamin D supplementation (60 000 international units monthly for 5 years) among Australians aged ≥60 years. KC outcomes were captured through linkage to a national administrative dataset for those who consented (N = 20 334; 95%). We used negative binomial regression to analyse the incidence of KC excisions and the incidence of actinic lesions treated using cryotherapy or serial curettage, and flexible parametric survival models for analysis of time to first KC excision. RESULTS: Randomization to vitamin D supplementation did not reduce the incidence of KC lesions treated by excision [incidence rate ratio (IRR) 1·04; 95% confidence interval (CI) 0·98-1·11], the incidence of actinic lesions treated using other methods (IRR 1·01; 95% CI 0·95-1·08) or time to first histologically confirmed KC excision (hazard ratio 1·02; 95% CI 0·97-1·08). However, in subgroup analysis vitamin D increased the incidence of KC excisions in adults aged ≥ 70 years (IRR 1·13, 95% CI 1·04-1·23; P-value for interaction = 0·01). CONCLUSIONS: Vitamin D supplementation did not reduce the incidence of KC or other actinic lesions. What is already known about this topic? Laboratory studies have suggested possible protective effects of vitamin D on skin cancer. Observational studies investigating the association between vitamin D and risk of keratinocyte cancer are largely uninformative as ultraviolet radiation both causes skin cancer and is the primary source of vitamin D. The evidence from randomized controlled trials of vitamin D is limited and inconclusive. What does this study add? This population-based, randomized controlled trial suggests that supplementing older adults with a high monthly dose of vitamin D for 5 years does not affect the incidence of keratinocyte cancer.
引用
- Ali S, Pham H, Waterhouse M, et al. The effect of vitamin D supplementation on risk of keratinocyte cancer: an exploratory analysis of the D-Health randomized controlled trial. Br J Dermatol. 2022. PMID: 35789991. doi:10.1111/bjd.21742
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。